# RNN 1st Gen Model Universal Health Services, Inc. General medical & surgical hospitals

Stock predictor AI models:
74.19% successful of 62 deals
$ 124.10 Last close price
at 29-oct-2021


Model's trade recommendations 0.23% Return for period

7.31% Annual return

$11.10B Market Cap

β 0.84  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 0.23%
52wk return -2.44%
52wk Range
Sortino ratio 0.89
Sharpe ratio 0.65
Norm. RMSE 0.76%
Downside risk 8.28%
Volatility 0.00%
  • 0.40 (0.34%) Div (Yield)
  • BUY Analysts consensus recommendation

Universal Health Services, Inc. is one of the nation's largest and most respected healthcare management companies, operating through its subsidiaries, behavioral health facilities, acute care hospitals and ambulatory centers throughout the United States, the United Kingdom and Puerto Rico. UHS maintains one of the strongest balance sheets and is rated amongst the highest in the hospital services industry by Moody's and Standard & Poor's. This strong capital position has enabled the company to develop and acquire many new facilities over the past few years.

Industry sector: Medical

Sector classification: General medical & surgical hospitals

Deep Learning based analysis and prediction model for Universal Health Services, Inc. (UHS) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for UHS model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for UHS.

Model is being retrained on a daily basis.

Float 83M
P/E 14.66
Shares Outstanding 94M
% Held by Insiders 12.30%
% Held by Institutions 87.97%
EPS (last reported FY) $7.53
EPS (last reported Q) $2.45
EPS, estimated (last reported Q) $2.59
Total revenues $10 B
Net income $1 B